Clinical Trial Update: 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 safety study in children aged 4-11 with allergic rhinitis evaluating Dymista nasal spray (azelastine hydrochloride and fluticasone propionate) and fluti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• DYMISTA (azelastine hydrochloride and fluticasone propionate)
• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: Meda Pharmaceuticals | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-03-31